(Q34693220)

English

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis (English)

1 reference

Europe PubMed Central

4 August 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

object named as

M Kudo

2

0 references

author name string

R Lencioni

1

1 reference

Europe PubMed Central

4 August 2017

S-L Ye

3

1 reference

Europe PubMed Central

4 August 2017

J-P Bronowicki

4

1 reference

Europe PubMed Central

4 August 2017

X-P Chen

5

1 reference

Europe PubMed Central

4 August 2017

L Dagher

6

1 reference

Europe PubMed Central

4 August 2017

J Furuse

7

1 reference

Europe PubMed Central

4 August 2017

J F Geschwind

8

1 reference

Europe PubMed Central

4 August 2017

L Ladrón de Guevara

9

1 reference

Europe PubMed Central

4 August 2017

C Papandreou

10

1 reference

Europe PubMed Central

4 August 2017

T Takayama

11

1 reference

Europe PubMed Central

4 August 2017

S K Yoon

12

1 reference

Europe PubMed Central

4 August 2017

K Nakajima

13

1 reference

Europe PubMed Central

4 August 2017

R Lehr

14

1 reference

Europe PubMed Central

4 August 2017

S Heldner

15

1 reference

Europe PubMed Central

4 August 2017

A J Sanyal

16

1 reference

Europe PubMed Central

4 August 2017

publication date

28 November 2013

1 reference

Europe PubMed Central

4 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

International Journal of Clinical Practice

1 reference

Europe PubMed Central

4 August 2017

68

1 reference

Europe PubMed Central

4 August 2017

5

1 reference

Europe PubMed Central

4 August 2017

609-617

1 reference

Europe PubMed Central

4 August 2017

Risk factors of hepatocellular carcinoma--current status and perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Epidemiology of viral hepatitis and hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Management of hepatocellular carcinoma: An update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Design and rationale for the non-interventional Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma and Of its Treatment with Sorafenib (GIDEON) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Staging systems in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Hepatocellular carcinoma development in cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Management of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Hepatocellular carcinoma: the need for progress.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Chemoembolization for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4265239

7 July 2018

Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12352

21 January 2018

First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12352

21 January 2018

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12352

21 January 2018

[Epidemiology, natural history and pathogenesis of hepatocellular carcinoma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24283303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system

1 reference

https://pubmed.ncbi.nlm.nih.gov/24283303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/IJCP.12352

1 reference

Europe PubMed Central

4 August 2017

PMC publication ID

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34693220&oldid=1766857243"